The blood flukes Schistosoma mansoni and Schistosoma japonicum inflict immense suffering as agents of human schistosomiasis. Previous investigations have found the nervous systems of these worms contain abundant immunoreactivity to antisera targeting invertebrate neuropeptide Fs (NPFs) as well as structurally similar neuropeptides of the mammalian neuropeptide Y (NPY) family. Here, cDNAs encoding NPF in these worms were identified, and the mature neuropeptides from the two species differed by only a single amino acid. Both neuropeptides feature the characteristics common among NPFs; they are 36 amino acids long with a carboxyl-terminal Gly-Arg-X-Arg-Phe-amide and Tyr residues at positions 10 and 17 from the carboxyl terminus. Synthetic S. mansoni NPF potently inhibits the forskolin-stimulated accumulation of cAMP in worm homogenates, with significant effects at 10 ؊11 M. This is the first demonstration of an endogenous inhibition of cAMP by an NPF, and because this is the predominant pathway associated with vertebrate NPY family peptides, it demonstrates a conservation of downstream signaling pathways used by NPFs and NPY peptides.Blood fluke parasites of the genus Schistosoma are the most important metazoan parasites of humans and are the etiological agents of schistosomiasis (bilharzia), which afflicts over 200 million people. Schistosomiasis ranks second, behind only malaria, in terms of its overall negative socio-economic and public health impact on the tropical and subtropical world, and it remains among the top five disease priorities of the World Health Organization (WHO) 1 (1). Control of the disease rests almost solely on chemotherapy using the anthelmintic praziquantel (2-4). Most disturbingly, the long term utility of praziquantel has been brought into question because of growing reports of infections not responding to the recommended dosage (5-8) and worms with decreased sensitivity (9, 10). WHO has accordingly identified research into the basic biology of schistosomes as a priority, with the hope of identifying targets for the next generation of antischistosomal drugs (1).Schistosomes belong to the class Trematoda of the phylum Platyhelminthes (flatworms) and, as such, are among the simplest extant animals to display brain development with the concomitant distinction between central and peripheral neuronal elements. One distinct feature of platyhelminths and other early diverging phyla is a prominent peptidergic component within their nervous systems. One family of neuropeptides abundant among these early animals is the neuropeptide F (NPF) family (11-14). NPFs are 36 -40-amino acid peptides featuring a carboxyl-terminal Gly-Arg-X-Arg-Phe-amide (GRXRF-NH 2 ) motif and tyrosine residues at positions 10 and 17 relative to the carboxyl terminus.These characteristics are common to those of vertebrate NPY family peptides, 36 amino acid neuropeptides with RXR(F/Y)-NH 2 carboxyl termini, Tyr residues at positions 10 and 17 relative to the carboxyl termini, and prolines in a PXXPXXP motif near the amino ter...